March 26, 2009 / 8:44 AM / 10 years ago

REFILE-Celesio sees EBITDA up by half in 2015

(Corrects date in dateline, typographical error in spelling of wholesaler in first paragraph)

STUTTGART, Germany, March 26 (Reuters) - Celesio CLSGn.DE is bracing for more earnings decline this quarter but raised the prospect of a gain in core earnings by more than half by 2015, the German drugs wholesaler said on Thursday.

Celesio, which also operates drug retail chains including Lloydspharmacy, posted a fourth-quarter net loss of 211.2 million euros ($286.7 million), worse than expected, on write-downs on pharmacies and a decline in the pound.

Analysts polled by Reuters had expected a loss of 192 million euros on average. ($1=.7366 Euro) (Reporting by Ludwig Burger)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below